What is a stock summary page? Click here for an overview.
Business Description
GENinCode PLC
ISIN : GB00BL97B504
Description
GENinCode PLC is engaged in the genetic risk assessment, prediction, and prevention of cardiovascular diseases including coronary artery diseases such as angina and myocardial infarction (heart attack), stroke, heart failure, hypertension, and other vascular heart diseases. The company's current product portfolio comprises Cardio inCode, LiPID inCode, SuDD inCode, and Thrombo inCode. The company has only one reportable segment the sale of kits and the provision of support services. The Geographic Markets of the group are Chile, France, Italy, Sweden, Mexico, Spain, and the United Kingdom.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.31 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -7.86 | |||||
| Beneish M-Score | -1.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 32 | |||||
| 3-Year EBITDA Growth Rate | -84.4 | |||||
| 3-Year EPS without NRI Growth Rate | -82.5 | |||||
| 3-Year FCF Growth Rate | -87.4 | |||||
| 3-Year Book Growth Rate | -11.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 0.54 | |||||
| 9-Day RSI | 9.68 | |||||
| 14-Day RSI | 24.08 | |||||
| 3-1 Month Momentum % | -6.58 | |||||
| 6-1 Month Momentum % | -47.41 | |||||
| 12-1 Month Momentum % | -26.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | |||||
| Quick Ratio | 2.55 | |||||
| Cash Ratio | 2 | |||||
| Days Inventory | 22.13 | |||||
| Days Sales Outstanding | 89.97 | |||||
| Days Payable | 322.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -36.2 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.44 | |||||
| Operating Margin % | -232.09 | |||||
| Net Margin % | -228.7 | |||||
| FCF Margin % | -233.67 | |||||
| ROE % | -201.15 | |||||
| ROA % | -111.66 | |||||
| ROIC % | -493.01 | |||||
| 3-Year ROIIC % | -467.38 | |||||
| ROC (Joel Greenblatt) % | -839.97 | |||||
| ROCE % | -161.22 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.45 | |||||
| PB Ratio | 1.91 | |||||
| Price-to-Tangible-Book | 3.05 | |||||
| EV-to-EBIT | -1.03 | |||||
| EV-to-Forward-EBIT | -1.51 | |||||
| EV-to-EBITDA | -1.09 | |||||
| EV-to-Forward-EBITDA | -2.11 | |||||
| EV-to-Revenue | 2.33 | |||||
| EV-to-Forward-Revenue | 1.4 | |||||
| EV-to-FCF | -1.23 | |||||
| Price-to-GF-Value | 0.2 | |||||
| Price-to-Net-Current-Asset-Value | 3.05 | |||||
| Price-to-Net-Cash | 3.05 | |||||
| Earnings Yield (Greenblatt) % | -97.37 | |||||
| FCF Yield % | -69.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GENinCode PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 2.599 | ||
| EPS (TTM) (£) | -0.054 | ||
| Beta | 2.78 | ||
| 3-Year Sharpe Ratio | -0.41 | ||
| 3-Year Sortino Ratio | -0.77 | ||
| Volatility % | 31.59 | ||
| 14-Day RSI | 24.08 | ||
| 14-Day ATR (£) | 0.001917 | ||
| 20-Day SMA (£) | 0.0346 | ||
| 12-1 Month Momentum % | -26.04 | ||
| 52-Week Range (£) | 0.03 - 0.1 | ||
| Shares Outstanding (Mil) | 286.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GENinCode PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GENinCode PLC Stock Events
| Event | Date | Price (£) | ||
|---|---|---|---|---|
| No Event Data | ||||
GENinCode PLC Frequently Asked Questions
What is GENinCode PLC(LSE:GENI)'s stock price today?
The current price of LSE:GENI is £0.03. The 52 week high of LSE:GENI is £0.10 and 52 week low is £0.03.
When is next earnings date of GENinCode PLC(LSE:GENI)?
The next earnings date of GENinCode PLC(LSE:GENI) is 2025-06-03 Est..
Does GENinCode PLC(LSE:GENI) pay dividends? If so, how much?
GENinCode PLC(LSE:GENI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers